Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidya L Ambati

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Association between Haloperidol use and Risk of Rheumatoid ArthritisVidya L Ambati, Tammy H Cummings, Praveen Yerramothu, et al.
JAMA Network Open|March 9, 2026
Fluticasone- vs Budesonide-Based Dual Therapy for COPDWilliam B Feldman, Vidya L Ambati, Samy Suissa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 9, 2025
Association of nucleoside reverse transcriptase inhibitor use with reduced risk of Alzheimer's disease riskJoseph Magagnoli, Meenakshi Ambati, Tammy H Cummings, et al.
Investigative Ophthalmology & Visual Science|August 5, 2020
A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium DegenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Reduction of human Alzheimer's disease risk and reversal of mouse model cognitive deficit with nucleoside analog useJoseph Magagnoli, Praveen Yerramothu, Kameshwari Ambati, et al.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Science Immunology|December 3, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAsShao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Science Advances|September 29, 2021
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunityShinichi Fukuda, Siddharth Narendran, Akhil Varshney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degenerationShinichi Fukuda, Akhil Varshney, Benjamin J Fowler, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Association between Haloperidol use and Risk of Rheumatoid ArthritisVidya L Ambati, Tammy H Cummings, Praveen Yerramothu, et al.
JAMA Network Open|March 9, 2026
Fluticasone- vs Budesonide-Based Dual Therapy for COPDWilliam B Feldman, Vidya L Ambati, Samy Suissa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 9, 2025
Association of nucleoside reverse transcriptase inhibitor use with reduced risk of Alzheimer's disease riskJoseph Magagnoli, Meenakshi Ambati, Tammy H Cummings, et al.
Investigative Ophthalmology & Visual Science|August 5, 2020
A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium DegenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Reduction of human Alzheimer's disease risk and reversal of mouse model cognitive deficit with nucleoside analog useJoseph Magagnoli, Praveen Yerramothu, Kameshwari Ambati, et al.
Signal Transduction and Targeted Therapy|April 14, 2021
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degenerationSiddharth Narendran, Felipe Pereira, Praveen Yerramothu, et al.
Science Immunology|December 3, 2021
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAsShao-Bin Wang, Siddharth Narendran, Shuichiro Hirahara, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Science Advances|September 29, 2021
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunityShinichi Fukuda, Siddharth Narendran, Akhil Varshney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
Cytoplasmic synthesis of endogenous <i>Alu</i> complementary DNA via reverse transcription and implications in age-related macular degenerationShinichi Fukuda, Akhil Varshney, Benjamin J Fowler, et al.
Pageof 1